Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivaroxaban for Patients with Intermittent Claudication.
Ramacciotti E, Volpiani GG, Britto KF, Agati LB, Ribeiro CM, Aguiar VCR, Paganotti A, Pereira FM, Caffaro RA, Krakauer R, Rached HRS, Fareed J, Wolosker N, Anand SS, Eikelboom JW, Chang C, Lopes RD. Ramacciotti E, et al. Among authors: rached hrs. NEJM Evid. 2024 Sep;3(9):EVIDoa2400021. doi: 10.1056/EVIDoa2400021. Epub 2024 Aug 26. NEJM Evid. 2024. PMID: 39185955 Clinical Trial.
Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial.
Ramacciotti E, Agati LB, Volpiani GG, Brito KF, Ribeiro CM, Aguiar VCR, Ramacciotti LS, Paganotti A, Pereira FM, Caffaro RA, Fioranelli A, Krakauer R, Rached HRS, Wolosker N, Anand SS, Eikelboom JW, Lopes RD. Ramacciotti E, et al. Among authors: rached hrs. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211073922. doi: 10.1177/10760296211073922. Clin Appl Thromb Hemost. 2022. PMID: 35043716 Free PMC article. Clinical Trial.
Brazilian Position Statement on the Use Of Multimodality Imaging in Cardio-Oncology - 2021.
Melo MDT, Paiva MG, Santos MVC, Rochitte CE, Moreira VM, Saleh MH, Brandão SCS, Gallafrio CC, Goldwasser D, Gripp EA, Piveta RB, Silva TO, Santo THCE, Ferreira WP, Salemi VMC, Cauduro SA, Barberato SH, Lopes HMC, Pena JLB, Rached HRS, Miglioranza MH, Pinheiro AC, Vrandecic BALM, Cruz CBBV, Nomura CH, Cerbino FME, Costa IBSDS, Coelho Filho OR, Carneiro ACC, Burgos UMMC, Fernandes JL, Uellendahl M, Calado EB, Senra T, Assunção BL, Freire CMV, Martins CN, Sawamura KSS, Brito MM, Jardim MFS, Bernardes RJM, Diógenes TC, Vieira LO, Mesquita CT, Lopes RW, Segundo Neto EMV, Rigo L, Marin VLS, Santos MJ, Grossman GB, Quagliato PC, Alcantara ML, Teodoro JAR, Albricker ACL, Barros FS, Amaral SID, Porto CLL, Barros MVL, Santos SND, Cantisano AL, Petisco ACGP, Barbosa JEM, Veloso OCG, Spina S, Pignatelli R, Hajjar LA, Kalil Filho R, Lopes MACQ, Vieira MLC, Almeida ALC. Melo MDT, et al. Among authors: rached hrs. Arq Bras Cardiol. 2021 Oct;117(4):845-909. doi: 10.36660/abc.20200266. Arq Bras Cardiol. 2021. PMID: 34709307 Free PMC article. English, Portuguese. No abstract available.
Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
Alves GB, Oliveira EM, Alves CR, Rached HR, Mota GF, Pereira AC, Rondon MU, Hashimoto NY, Azevedo LF, Krieger JE, Negrão CE. Alves GB, et al. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):487-92. doi: 10.1097/HJR.0b013e32832c5a8a. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19404196 Clinical Trial.